Treatment · Gland restoration

Meibomian Gland Probing & Restoration

When meibomian glands become severely obstructed, scarred, or atrophic, they stop producing the lipid layer your tears need. Meibomian gland probing opens scarred ducts, clears years of accumulated debris, and restores the glands that conventional therapy alone cannot help.

Book Assessment

30–40

meibomian glands per
upper eyelid

20 min

per eyelid
treatment time

1–3

sessions depending on
severity

4–8 wk

typical time to
full benefit

What it is

When Drops and Devices Aren’t Enough

Meibomian gland probing is a specialized procedure that addresses the root cause when conventional therapies fail: glands that are scarred shut, clogged with years of inspissated (thickened) meibum, or too severely damaged to respond to IPL, LipiFlow, or warm compresses alone. Instead of coaxing a diseased gland to work, probing opens the gland architecture, clears the obstruction, and restores the anatomy that lipid production depends on.

This matters because the meibomian glands produce the lipid layer—the outermost, oiliest layer of your tears. This layer is what keeps tears from evaporating. When these glands stop functioning, no amount of water-based artificial tears will solve the problem. Your ocular surface needs the lipid layer restored. Probing makes that possible.

For the most severe meibomian gland disease

Not every patient with dry eye needs probing. Most respond well to UltraView DEL, LipiFlow, or heat-based therapies. Probing is reserved for the severe end of the spectrum—patients with >30% gland dropout, duct obstruction that’s resistant to conventional opening techniques, or a pattern of recurring clogging despite aggressive home care. If that’s your clinical picture, probing is often transformative.

Foundation

The Meibomian Gland Architecture

Each eyelid contains 30–40 meibomian glands (upper lid) and 20–30 (lower lid). These are specialized sebaceous glands embedded deep in the eyelid tissue, with each gland running vertically through the lid and opening onto the lid margin—the edge of your eyelid where the lashes emerge. Each gland produces a lipid-rich secretion (meibum) that spreads across the tear film when you blink.

When glands become diseased, the chain of dysfunction unfolds like this:

Inflammation or infection triggers swelling and accumulation of bacteria and biofilm in the gland duct
Meibum becomes inspissated (thickened and plug-like), clogging the duct opening
The duct scar tissue forms around the obstruction, fibrosis narrows the opening further
Gland pressure backs up, damaging the gland tissue itself
Chronic inflammation causes atrophy—the gland cells die and are replaced by scar tissue
The gland becomes non-functional, producing little to no lipid and no longer responding to conventional opening techniques

This cascade explains why warm compresses alone often fail: once scarring and structural damage occur, mechanical pressure alone cannot reliably reopen and heal the gland. Probing addresses this by mechanically restoring the gland anatomy and clearing the obstruction—essentially resetting the gland back to a state where healing and regeneration become possible.

How it works

The Probing & Restoration Protocol

Meibomian gland probing is performed under high magnification, with profound numbing to ensure comfort. The procedure usually takes 15–25 minutes per eyelid and can be completed in a single visit.

Numbing

Topical anesthetic drops and contact anesthetic are applied to the ocular surface and lid margin. The goal is complete comfort during the procedure—you’ll feel pressure and motion, not pain.

Magnification

Using a surgical microscope or high-power slit lamp, the ophthalmologist visualises individual meibomian gland openings along your lid margin and assesses which glands are obstructed and need probing.

Probe insertion

A fine, blunt-tipped probe is gently introduced into the gland opening and advanced slowly into the gland duct, feeling for resistance and obstruction as it advances.

Clearing obstruction

The probe gently opens fibrosed or scarred ducts and breaks apart the inspissated meibum plug. The probe is withdrawn and re-introduced to ensure the duct is clear.

Expression

Once the duct is open, gentle pressure is applied to the lid to express the freed-up meibum and clear any remaining debris from the gland.

Anti-inflammatory therapy

An anti-inflammatory drop or ointment is applied to the treated gland opening to reduce inflammation and support healing.

Repeat for additional glands

The process is repeated for each severely obstructed gland—typically 5–15 glands per eyelid, depending on severity. Both eyelids are usually treated on the same day.

Post-treatment comfort

Immediately after probing, the eyelid may feel tender and sensitive. Tearing and mild redness are normal. Most patients describe mild discomfort (not severe pain) for the first few hours, which settles within 24 hours. Over-the-counter pain relief and cold compresses help. You can usually return to normal activity the same day.

Who benefits

Ideal Candidates for Probing

Not every patient with dry eye needs probing. The ideal candidate has severe meibomian gland dysfunction that is unresponsive to conventional therapy and documented on imaging.

Severe meibomian gland dysfunction (MGD)

Moderate-to-severe dry eye with duct obstruction and gland dropout visible on meibography, unresponsive to UltraView DEL, LipiFlow, warm compresses, or lid hygiene alone.

MGD

Significant gland dropout

>30% loss of meibomian gland tissue on imaging. Once gland loss reaches this threshold, conventional heat and expression therapies alone rarely restore function.

Structural

Posterior blepharitis with obstruction

Chronic posterior blepharitis (inflammation at the lid margin) with documented meibomian duct obstruction and fibrosis that resists lid margin cleaning and heat therapy.

Inflammation

Refractory dry eye with MGD

Persistent, severe evaporative dry eye despite optimised tear supplementation, anti-inflammatories, and conventional gland therapies—where the underlying gland damage is clearly documented.

Refractory

Post-surgical dry eye with gland involvement

Severe dry eye after LASIK, PRK, or cataract surgery where underlying meibomian dysfunction is a significant contributor and standard therapies have not fully resolved the surface disease.

Post-operative

Not ideal candidates

Mild-to-moderate MGD (respond well to UltraView DEL or LipiFlow), aqueous-deficient dry eye without gland disease, or glands with near-total atrophy (irreversible scarring) are poor fits for probing.

Screening

The right candidates have two things: severe, documented gland disease AND failed adequate trials of conventional therapy. During your comprehensive evaluation, we’ll assess whether probing is the logical next step, or whether additional optimisation of other treatments might come first.

Timeline and improvement

What Happens After Probing

Healing after probing is gradual. The gland architecture has been restored, but the gland tissue itself needs time to regenerate function and for inflammation to settle.

Week 1: Post-procedure soreness resolves; you’ll likely notice some improvement in discomfort as the swollen lid settles
Weeks 2–4: Glands begin expressing meibum more freely; tear film stability improves; many patients notice measurable reduction in grittiness and foreign-body sensation
Month 2: Full gland function is often evident on examination; tear film quality is significantly improved; subjective comfort often matches objective findings
Month 3: Stable, optimal benefit is usually achieved; reduction in artificial tear dependency is common; most patients experience sustained improvement

For the right candidate, the results can be dramatic—transforming a patient from severe, refractory dry eye to functional stability. That said, probing is not magic. A meaningful minority of patients experience modest improvement, and we’ll reassess at the one-month mark and adjust the plan if the response is less than expected. In some cases, second sessions or layering with other therapies (like UltraView DEL) optimises the outcome further.

Connected care

Layering Meibomian Gland Restoration Across the UVG Network

Meibomian gland probing is almost never used in isolation. For best results, it’s layered with other treatments and maintained through coordinated home care across the UVG ecosystem.

Before or after probing, UltraView DEL? Many patients benefit from UltraView DEL™ (intense pulsed light for meibomian gland disease). Some clinicians prefer probing first, then DEL to optimise gland reopening; others reverse the order. The clinical picture guides sequencing—we’ll recommend the most logical pathway for your specific presentation.

Post-operative dry eye after cataract or refractive surgery? Probing is often part of the solution for severe post-surgical dry eye when gland involvement is present. Our colleagues at Uptown Eye Specialists (cataract surgery) and U Eye Laser Cosmetic (LASIK, PRK, SMILE) refer complex cases to UDEI for probing and advanced surface management—coordinated in one chart.

Maintaining results at home. After probing, diligent home care is essential: warm compresses 10–15 minutes daily, gentle lid hygiene, omega-3 supplementation, and preservative-free tears. Products curated for post-probing recovery are available through U Shoppe.

Long-term follow-up. We reassess at 1 month, 3 months, and every 6–12 months thereafter. Most patients maintain their improvement with home care alone; some benefit from periodic touch-up sessions or topical therapies to prevent gland re-obstruction.

Common questions

Frequently Asked Questions

No. Topical anesthesia is applied generously, and contact anesthetic numbs the lid margin completely. You’ll feel pressure and motion during the procedure, but not pain. Immediately after, the lid is tender for a few hours—manageable with over-the-counter pain relief and cold compresses. Most patients describe the discomfort as mild, not severe.

The number of glands treated depends on your dry eye severity and which glands are obstructed on examination. Typically, 5–15 glands per eyelid are probed. Both upper and lower eyelids can be treated on the same day, or the procedure can be split across two visits depending on the clinical picture and your comfort. Your ophthalmologist will discuss the plan after examining you.

Most candidates respond well. But if your follow-up examination at 1 month shows insufficient improvement, we’ll reassess. Options include a second probing session, layering with UltraView DEL, or referral to another treatment pathway. The goal is always to find the combination that works for your unique dry eye type. If probing wasn’t the right tool, we’ll adjust accordingly rather than continuing a treatment that isn’t delivering benefit.

With proper home care—warm compresses daily, gentle lid hygiene, and omega-3 supplementation—recurrent obstruction is minimised but not eliminated. Some patients maintain improvement indefinitely with home care alone. Others benefit from periodic touch-up sessions or adjunctive therapies (like annual UltraView DEL) to prevent re-obstruction over years. We’ll discuss a long-term maintenance plan during your follow-up visits.

Absolutely. In fact, layering is common. For severe MGD, the most effective pathway is often probing plus UltraView DEL—one mechanically restores gland architecture; the other uses light to reduce inflammation and stimulate regeneration. LipiFlow can also complement probing, though probing alone usually provides sufficient mechanical clearing that additional thermal pulsation may not be needed immediately. Timing and sequencing depend on your clinical picture; we’ll recommend the optimal combination at your evaluation.

Take the next step

When glands need restoration

If you’ve tried UltraView DEL, LipiFlow, warm compresses, and lid hygiene and your meibomian glands are still severely obstructed and non-functional, probing may be the treatment that finally addresses the root cause. UDEI has the expertise and facilities to perform meibomian gland probing with precision and integrate it into a comprehensive dry eye plan tailored to your clinical picture.